Onchocerciasis-associated epilepsy: an update and future perspectives

Trends Parasitol. 2023 Feb;39(2):126-138. doi: 10.1016/j.pt.2022.11.010. Epub 2022 Dec 15.

Abstract

Onchocerciasis-associated epilepsy (OAE) is an important neglected public health problem in areas with high ongoing onchocerciasis transmission. The risk that children in such areas develop epilepsy is related to their Onchocerca volvulus microfilarial (mf) load. Before the implementation of mass treatment with ivermectin, microfilariae were detected in cerebrospinal fluid (CSF). More recently, neither O. volvulus microfilariae nor DNA were detected in CSF or brain tissue; however, these samples were obtained years after seizure onset. It is possible that during fever-induced increased blood-brain barrier permeability, microfilariae enter the brain and, upon dying, cause an inflammatory reaction inducing seizures. Including OAE in the onchocerciasis disease burden estimation may mobilise extra resources for onchocerciasis disease elimination and treatment/care of OAE-affected persons/families.

Keywords: cerebrospinal fluid; epilepsy; ivermectin; nodding syndrome; onchocerciasis; pathogenesis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Child
  • Epilepsy* / drug therapy
  • Epilepsy* / etiology
  • Humans
  • Ivermectin / therapeutic use
  • Microfilariae
  • Onchocerca volvulus*
  • Onchocerciasis* / complications
  • Onchocerciasis* / drug therapy
  • Onchocerciasis* / epidemiology
  • Seizures / complications

Substances

  • Ivermectin